Men's Health

ArteraAI and Movember Announce New Relationship

Retrieved on: 
Tuesday, March 12, 2024

“We are privileged to stand shoulder to shoulder with industry leaders in the battle against prostate cancer,” said Andre Esteva, CEO and co-founder of ArteraAI.

Key Points: 
  • “We are privileged to stand shoulder to shoulder with industry leaders in the battle against prostate cancer,” said Andre Esteva, CEO and co-founder of ArteraAI.
  • The study successfully validated ArteraAI's prognostic model in advanced prostate cancer, demonstrating stronger prognostic correlations than individual clinical factors.
  • ArteraAI looks forward to its continued work with these organizations as there are several ongoing initiatives in the early development phase.
  • For more information on ArteraAI, visit Artera.ai .

Topo Athletic Taps Tantrum Agency As New Creative Agency of Record

Retrieved on: 
Wednesday, April 3, 2024

FRAMINGHAM, Mass., April 3, 2024 /PRNewswire/ -- Topo Athletic (Topo), a leading provider of performance athletic and outdoor footwear, is excited to announce its strategic partnership with award-winning creative agency Tantrum Agency (Tantrum).

Key Points: 
  • FRAMINGHAM, Mass., April 3, 2024 /PRNewswire/ -- Topo Athletic (Topo), a leading provider of performance athletic and outdoor footwear, is excited to announce its strategic partnership with award-winning creative agency Tantrum Agency (Tantrum).
  • Tantrum, selected after a competitive nationwide search, will serve as the company's strategic and creative agency of record.
  • Tantrum will work with the Topo team on brand communication, campaign development and digital marketing to elevate brand awareness and expand Topo's reach in the athletic footwear market.
  • "Partnering with Topo Athletic has truly felt like a natural fit for us," said David Tann, founder and CEO of Tantrum.

AI-Integrated Robotic Hair Restoration Revolutionizes Quality Of Life At Dallas Men's Health

Retrieved on: 
Thursday, March 28, 2024

DALLAS, March 28, 2024 /PRNewswire/ -- Dallas Men's Health (DMH), a men's sexual health and aesthetics clinic, proudly introduces new additions to its line of services: ARTAS iXi, an AI-Integrated Robotic Hair Restoration solution.

Key Points: 
  • DALLAS, March 28, 2024 /PRNewswire/ -- Dallas Men's Health (DMH), a men's sexual health and aesthetics clinic, proudly introduces new additions to its line of services: ARTAS iXi, an AI-Integrated Robotic Hair Restoration solution.
  • The addition of these capabilities unites the 25 years of medical expertise from Dr. Michael Wierschem with the precision of AI-driven, robotic hair restoration solutions.
  • "Adding ARTAS AI-integrated Automated Hair Restoration to our suite of men's wellness services furthers our commitment to comfortably improve men's health and well-being.
  • The novel AI-driven robotic hair restoration service uses minimally-invasive follicle-unit extraction and implantation technology that does not leave a linear scar, promotes comfort, and requires less recovery time than other treatments.

Therabody Expands Investment in Science with $10 Million Research Pledge, Scientific Partnerships and Official Scientific Advisory Board

Retrieved on: 
Tuesday, March 12, 2024

LOS ANGELES, March 12, 2024 /PRNewswire/ -- Therabody, the leader in wellness technology, announced today the investment of more than $10M to fund initiatives that will continue to drive innovation and the scientific validation of their products. The company also announced the formalization of their Scientific Advisory Board and, significantly, a partnership with the American College of Sports Medicine (ACSM), the global research leader in the field of exercise, physical fitness and sports medicine.

Key Points: 
  • In an evolving regulatory landscape, Therabody believes that science is essential for leading the way forward as technology will transform healthcare over the next decade.
  • Their $10 million investment in scientific research will drive an integrated strategy for scientific leadership in the industry with funds put toward scientific and clinical research studies across beauty, wellness and athletic performance over the next several years.
  • Our Scientific Advisory Board, along with our significant investment in scientific research and partnerships, will ensure we remain at the forefront of our industry and dedicated to developing the most effective, scientifically validated products available today and in the future," said Monty Sharma, President and CEO of Therabody.
  • Therabody has completed 21 scientific studies to date with 26 currently in progress.

Therabody Expands Investment in Science with $10 Million Research Pledge, Scientific Partnerships and Official Scientific Advisory Board

Retrieved on: 
Tuesday, March 12, 2024

LOS ANGELES, March 12, 2024 /PRNewswire/ -- Therabody, the leader in wellness technology, announced today the investment of more than $10M to fund initiatives that will continue to drive innovation and the scientific validation of their products. The company also announced the formalization of their Scientific Advisory Board and, significantly, a partnership with the American College of Sports Medicine (ACSM), the global research leader in the field of exercise, physical fitness and sports medicine.

Key Points: 
  • In an evolving regulatory landscape, Therabody believes that science is essential for leading the way forward as technology will transform healthcare over the next decade.
  • Their $10 million investment in scientific research will drive an integrated strategy for scientific leadership in the industry with funds put toward scientific and clinical research studies across beauty, wellness and athletic performance over the next several years.
  • Our Scientific Advisory Board, along with our significant investment in scientific research and partnerships, will ensure we remain at the forefront of our industry and dedicated to developing the most effective, scientifically validated products available today and in the future," said Monty Sharma, President and CEO of Therabody.
  • Therabody has completed 21 scientific studies to date with 26 currently in progress.

Americans Still in the Dark: New Data from MyFitnessPal Reveals Sizable Continuing Gaps in Basic Nutritional Knowledge

Retrieved on: 
Thursday, March 7, 2024

NEW YORK, March 7, 2024 /PRNewswire/ -- The beginning of a new year is when health and wellness are top of mind for consumers, but new data reveals ongoing gaps in nutrition knowledge of Americans that could be hindering their personal goals. MyFitnessPal, the leading global nutrition and food tracking app, recently conducted their Nutrition IQ 2.0 survey1, in follow up to initial results from 2022. Trends from the data show that Americans have more to learn in 2024, with the majority of Americans still unaware of the nutritional value and content in their daily diet. With the data showing that Americans' knowledge of nutrition has not deepened significantly over the past two years, MyFitnessPal formed a scientific advisory council to guide the development of nutrition content, tools, and features that support members in achieving their health and nutrition goals.

Key Points: 
  • MyFitnessPal , the leading global nutrition and food tracking app, recently conducted their Nutrition IQ 2.0 survey1, in follow up to initial results from 2022.
  • Trends from the data show that Americans have more to learn in 2024, with the majority of Americans still unaware of the nutritional value and content in their daily diet.
  • Compared to 2022, Americans are still overestimating calorie count and protein content, while underestimating fat and carb content.
  • A majority of Scott's clients are males looking to lose weight, but they're also looking to address longevity and gut health.

HAVAS REFORMS THE TRADITIONAL ADVERTISING MODEL WITH THE LAUNCH OF HAVAS CONSUMER HEALTH

Retrieved on: 
Tuesday, February 13, 2024

LONDON, Feb. 13, 2024 /PRNewswire/ - Havas announced today the launch of Havas Consumer Health (HCH), their Creative Network's first lifestyle health & wellness brand agency specializing in accessible OTC and wellness brands.

Key Points: 
  • LONDON, Feb. 13, 2024 /PRNewswire/ - Havas announced today the launch of Havas Consumer Health (HCH), their Creative Network's first lifestyle health & wellness brand agency specializing in accessible OTC and wellness brands.
  • HCH marries experience and a deep understanding of health & wellness marketing from Havas Health & You, the global leader in health and wellness communications, with the creative and consumer-focused excellence of the Havas Creative Network.
  • "Havas Consumer Health is a uniquely blended agency born from the insight that consumers are increasingly taking ownership of their health and wellness," shared Donna Murphy, Global CEO of Havas Health & You and Havas Creative Network.
  • "The most competitive brands recognize the value in separating their consumer health businesses to meet changing consumer needs," explained Dan Weaden, Havas Consumer Health CEO.

New Studies Demonstrate that Bot Image's Prostate Cancer AI Software Outperforms the Field

Retrieved on: 
Tuesday, January 30, 2024

and BELGRADE, Maine, Jan. 30, 2024 /PRNewswire/ -- Bot Image, Inc., a Nebraska and Maine based Artificial Intelligence medical device company ( www.botimageai.com ), raised the performance bar with its FDA-cleared AI software ProstatID™.

Key Points: 
  • and BELGRADE, Maine, Jan. 30, 2024 /PRNewswire/ -- Bot Image, Inc., a Nebraska and Maine based Artificial Intelligence medical device company ( www.botimageai.com ), raised the performance bar with its FDA-cleared AI software ProstatID™.
  • The unique trifecta clearance of this software used for prostate cancer detection, diagnosis and screening using non-invasive/non-contrast "short-form" of MRI sequences known as bi-parametric MRI (bpMRI) has demonstrated standalone performance of 93.6% AUROC (area under the sensitivity – specificity curve).
  • This is in stark contrast to results reported in recent articles reporting other Prostate AI products.
  • "Furthermore, if results are not reported in terms of the standalone performance of such software, then it's like comparing apples to oranges.

Los Angeles Vasectomy and Vasectomy Reversal Specialist, Dr. Justin Houman, is Appointed Assistant Professor at Cedars-Sinai Medical Center

Retrieved on: 
Tuesday, January 23, 2024

LOS ANGELES, Jan. 23, 2024 /PRNewswire-PRWeb/ -- As an esteemed assistant professor in urology at Cedars-Sinai Medical Center, Dr. Justin Houman will continue enhancing the quality of life for men by improving their sexual, reproductive and hormonal health. Dr. Houman provides his patients with the latest and most effective treatments available, with extensive expertise in vasectomy, vasectomy reversal, infertility, testosterone, Peyronie's disease, erectile dysfunction and urology. Also, as a top minimally invasive microscopic surgeon, Dr. Houman delivers skill and expertise in microsurgical varicocelectomies, vasectomy reversals, sperm retrievals, penile implants and male incontinence. His vast knowledge and experience in urology have earned him recognition as a leading authority in men's health. Dr. Houman's appointment at Cedars-Sinai Medical Center is a testament to his exceptional skills, dedication and unwavering commitment to patient care. As an assistant professor, Dr. Houman will continue to contribute to the advancement of urological research and education for his patients and students.

Key Points: 
  • Board-certified and fellowship-trained urologist, Dr. Justin Houman, is a top men's health specialist and leading urological surgeon in the Los Angeles area.
  • LOS ANGELES, Jan. 23, 2024 /PRNewswire-PRWeb/ -- As an esteemed assistant professor in urology at Cedars-Sinai Medical Center, Dr. Justin Houman will continue enhancing the quality of life for men by improving their sexual, reproductive and hormonal health.
  • Dr. Houman provides his patients with the latest and most effective treatments available, with extensive expertise in vasectomy, vasectomy reversal , infertility, testosterone, Peyronie's disease, erectile dysfunction and urology.
  • Dr. Houman's appointment at Cedars-Sinai Medical Center is a testament to his exceptional skills, dedication and unwavering commitment to patient care.

Craft Medical Evolves to Craft Men's Clinic, Reflecting Its Dedication to Men's Health

Retrieved on: 
Monday, January 22, 2024

TULSA, Okla., Jan. 22, 2024 /PRNewswire/ -- Craft Medical, a leader in men's telehealth services, is excited to announce its rebranding to Craft Men's Clinic, a Craft Health Company.

Key Points: 
  • TULSA, Okla., Jan. 22, 2024 /PRNewswire/ -- Craft Medical, a leader in men's telehealth services, is excited to announce its rebranding to Craft Men's Clinic, a Craft Health Company.
  • This change is not just in name but also a reaffirmation of our dedication to men's health and hormone optimization, focusing on online healthcare solutions.
  • Since its inception, Craft Medical has been at the forefront of providing personalized medical care remotely, specializing in testosterone replacement therapy (TRT).
  • "We've always been passionate about men's health, and renaming ourselves Craft Men's Clinic solidifies our commitment to this cause.